All questionsPharmacology: Foundayo (orforglipron) in chronic weight management7 questions · 2 sourcesMechanismIs Foundayo a GLP-1 receptor agonist?“FOUNDAYO™ is a GLP-1 receptor agonist indicated in combination with a reduced-calorie diet” (opens the source at this quote in a new tab)CopyFlag“FOUNDAYO contains orforglipron, a GLP-1 receptor agonist.” (opens the source at this quote in a new tab)CopyFlagHow does Foundayo work (mechanism of action)?“FOUNDAYO is a GLP-1 receptor agonist that binds to and activates the human GLP-1 receptor. GLP-1 is a physiological regulator of appetite and caloric intake. GLP-1 receptors are present in brain regions that regulate appetite. In animal studies, orforglipron distributed to and activated neurons in brain regions that regulate appetite and food intake.” (opens the source at this quote in a new tab)CopyFlag“FOUNDAYO reduces body weight, with greater fat mass loss than lean mass loss. FOUNDAYO decreases food intake. This effect is likely mediated by decreased appetite.” (opens the source at this quote in a new tab)CopyFlag“FOUNDAYO delays gastric emptying. The delay is largest after the first dose and diminishes over time.” (opens the source at this quote in a new tab)CopyFlagIs Foundayo a peptide or a small molecule?“A GLP-1 RA with a non-peptide, small molecule design1,2” (opens the source at this quote in a new tab)CopyFlag“Foundayo is a small molecule, oral GLP-1 receptor agonist.1,2” (opens the source at this quote in a new tab)CopyFlag“GLP-1 RA=glucagon-like peptide-1 receptor agonist” (opens the source at this quote in a new tab)CopyFlagNote: These passages are from the home page of the Foundayo HCP site, which cites the Prescribing Information and Kawai et al., Proc Natl Acad Sci U S A 2020.PharmacokineticsHow long does Foundayo stay in your system (half-life)?“The mean systemic clearance of orforglipron is 7.15 L/hour. The elimination half-life is approximately 29 to 49 hours after an oral dose.” (opens the source at this quote in a new tab)CopyFlag“Steady state exposure is achieved after approximately 1 week of once daily administration.” (opens the source at this quote in a new tab)CopyFlagHow is Foundayo metabolized?“Metabolism Orforglipron is metabolized primarily via hepatic CYP3A4 to several oxidative metabolites. These oxidative metabolites are excreted into the intestinal lumen. Excretion After administration of a single oral dose of 2.5 mg orforglipron, 87% of the dose was recovered in feces (all metabolites) and less than 1% of the dose was recovered in urine.” (opens the source at this quote in a new tab)CopyFlag“Orforglipron is a substrate of CYP3A4 and CYP2J2, and is not a substrate of CYP1A2, CYP2B6, CYP2C8, CYP2C19, CYP2D6, and CYP3A5.” (opens the source at this quote in a new tab)CopyFlagWhat is the oral bioavailability of Foundayo?“Maximum concentration of orforglipron is reached 4 to 8 hours post dose. Orforglipron tablet exposure increases in a dose-proportional manner. The geometric mean absolute bioavailability of orforglipron was 77% after a 0.8 mg dose.” (opens the source at this quote in a new tab)CopyFlagComponentsWhat are the inactive ingredients in Foundayo?“Each tablet contains the following inactive ingredients: copovidone, crospovidone, magnesium stearate, microcrystalline cellulose, and sodium carbonate anhydrous. The tablet film-coating material contains polyethylene glycol, polyvinyl alcohol, talc, and titanium dioxide. Additionally, the film coating of the: 0.8 mg and 9 mg tablets contain ferric oxide red and ferric oxide yellow 2.5 mg and 14.5 mg tablets contain ferric oxide yellow 5.5 mg and 17.2 mg tablets contain ferrosoferric oxide and ferric oxide red. Each tablet contains 10 mg or less of sodium.” (opens the source at this quote in a new tab)CopyFlag